Regional Anaesthesia and Substance P in Head and Neck Cancer
Status:
Unknown status
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
In the clinical trial the investigators will observe the impact of regional anesthesia in
addition to a general anesthesia on the expression of substance P in patients with unilateral
Head or Neck cancer undergoing unilateral Neck Dissection. The investigators will perform an
unilateral regional cervical plexus block on the tumor side. The tissue of the tumor side
will be analysed by immunohistology, measuring the expression of the Substance P.